Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
29346 | 188 | 38.0 | 92% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
111 | 3 | THROMBOSIS RESEARCH//THROMBOSIS AND HAEMOSTASIS//HEMATOLOGY | 71244 |
707 | 2 | MATRIX METALLOPROTEINASE//METALLOPROTEINASES//MT1 MMP | 12920 |
29346 | 1 | RECK//REVERSION INDUCING CYSTEINE RICH PROTEIN WITH KAZAL MOTIFS//RECK GENE | 188 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | RECK | authKW | 9746529 | 47% | 67% | 89 |
2 | REVERSION INDUCING CYSTEINE RICH PROTEIN WITH KAZAL MOTIFS | authKW | 1799141 | 6% | 92% | 12 |
3 | RECK GENE | authKW | 324845 | 1% | 100% | 2 |
4 | REVERSION INDUCING CYSTEINE RICH PROTEIN WITH KAZAL MOTIFS RECK | authKW | 324845 | 1% | 100% | 2 |
5 | MIR 590 5P | authKW | 243631 | 2% | 50% | 3 |
6 | ONCOL MOL BIOL | address | 173245 | 2% | 27% | 4 |
7 | 3 D CELL INVASION ASSAY | authKW | 162423 | 1% | 100% | 1 |
8 | AFFILIATED HOSP QIQIHAR 5 | address | 162423 | 1% | 100% | 1 |
9 | BASIL CELL CARCINOMA | authKW | 162423 | 1% | 100% | 1 |
10 | BENZOYLUREA DERIVATIVE | authKW | 162423 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 1287 | 43% | 0% | 81 |
2 | Cell Biology | 492 | 27% | 0% | 51 |
3 | Biochemistry & Molecular Biology | 91 | 22% | 0% | 41 |
4 | Pathology | 78 | 6% | 0% | 12 |
5 | Medicine, Research & Experimental | 75 | 9% | 0% | 16 |
6 | Genetics & Heredity | 21 | 6% | 0% | 11 |
7 | Gastroenterology & Hepatology | 17 | 4% | 0% | 7 |
8 | Integrative & Complementary Medicine | 11 | 1% | 0% | 2 |
9 | Biophysics | 10 | 4% | 0% | 7 |
10 | Dentistry, Oral Surgery & Medicine | 7 | 2% | 0% | 4 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ONCOL MOL BIOL | 173245 | 2% | 27% | 4 |
2 | AFFILIATED HOSP QIQIHAR 5 | 162423 | 1% | 100% | 1 |
3 | BIOCHEMCELL MOL THER Y NUCEL NETCEM | 162423 | 1% | 100% | 1 |
4 | CANC HOSP ONCOLSHANGHAI MED | 162423 | 1% | 100% | 1 |
5 | CENTURY COE FORMAT 21ST | 162423 | 1% | 100% | 1 |
6 | MOL MECH CYTOPROTECT | 162423 | 1% | 100% | 1 |
7 | QIHU HOSP | 162423 | 1% | 100% | 1 |
8 | UQCCRROYAL BRISBANE WOMENS HOSP | 162423 | 1% | 100% | 1 |
9 | 21ST CENTURY COE FORMAT | 81210 | 1% | 50% | 1 |
10 | BIOCHEMCHEM | 81210 | 1% | 50% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ONCOGENE | 889 | 5% | 0% | 10 |
2 | AMERICAN JOURNAL OF CANCER RESEARCH | 820 | 1% | 0% | 2 |
3 | JOURNAL OF MOLECULAR HISTOLOGY | 805 | 1% | 0% | 2 |
4 | ONCOTARGETS AND THERAPY | 761 | 2% | 0% | 3 |
5 | CANCER SCIENCE | 732 | 2% | 0% | 4 |
6 | ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY HEAD AND NECK SURGERY | 698 | 1% | 0% | 1 |
7 | CANCER AND METASTASIS REVIEWS | 530 | 1% | 0% | 2 |
8 | MEDICAL SCIENCE MONITOR | 332 | 2% | 0% | 3 |
9 | CELLULAR SIGNALLING | 331 | 2% | 0% | 3 |
10 | ONCOTARGET | 324 | 3% | 0% | 5 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | NAGINI, S , (2012) RECKING MMP: RELEVANCE OF REVERSION-INDUCING CYSTEINE-RICH PROTEIN WITH KAZAL MOTIFS AS A PROGNOSTIC MARKER AND THERAPEUTIC TARGET FOR CANCER (A REVIEW).ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. VOL. 12. ISSUE 7. P. 718 -725 | 47 | 68% | 9 |
2 | NODA, M , TAKAHASHI, C , (2007) RECKLESSNESS AS A HALLMARK OF AGGRESSIVE CANCER.CANCER SCIENCE. VOL. 98. ISSUE 11. P. 1659 -1665 | 36 | 67% | 47 |
3 | RABIEN, A , ERGUN, B , ERBERSDOBLER, A , JUNG, K , STEPHAN, C , (2012) RECK OVEREXPRESSION DECREASES INVASIVE POTENTIAL IN PROSTATE CANCER CELLS.PROSTATE. VOL. 72. ISSUE 9. P. 948-954 | 26 | 79% | 13 |
4 | LIANG, QX , LIANG, YC , XU, ZY , CHEN, WL , XIE, HL , ZHANG, B , (2014) RECK OVEREXPRESSION REDUCES INVASIVE ABILITY IN AMELOBLASTOMA CELLS.JOURNAL OF ORAL PATHOLOGY & MEDICINE. VOL. 43. ISSUE 8. P. 613 -618 | 23 | 72% | 1 |
5 | TIAN, QS , LI, DC , (2010) LENTIVIRUS-MEDIATED REVERSION-INDUCING CYSTEINE-RICH PROTEIN WITH KAZAL MOTIFS GENE TRANSFER SUPPRESSES PANCREATIC CANCER INVASION IN VITRO.SAUDI MEDICAL JOURNAL. VOL. 31. ISSUE 7. P. 752 -758 | 21 | 78% | 3 |
6 | SHI, GP , YOSHIDA, Y , YUKI, K , NISHIMURA, T , KAWATA, Y , KAWASHIMA, M , IWAISAKO, K , YOSHIKAWA, K , KUREBAYASHI, J , TOI, M , ET AL (2016) PATTERN OF RECK CPG METHYLATION AS A POTENTIAL MARKER FOR PREDICTING BREAST CANCER PROGNOSIS AND DRUG-SENSITIVITY.ONCOTARGET. VOL. 7. ISSUE 50. P. 82158 -82169 | 23 | 55% | 0 |
7 | CHEN, Y , TSENG, SH , (2012) THE POTENTIAL OF RECK INDUCERS AS ANTITUMOR AGENTS FOR GLIOMA.ANTICANCER RESEARCH. VOL. 32. ISSUE 7. P. 2991 -2998 | 34 | 38% | 8 |
8 | ZHANG, CS , LING, Y , ZHANG, CH , XU, Y , GAO, L , LI, R , ZHU, J , FAN, LY , WEI, LX , (2012) THE SILENCING OF RECK GENE IS ASSOCIATED WITH PROMOTER HYPERMETHYLATION AND POOR SURVIVAL IN HEPATOCELLULAR CARCINOMA.INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES. VOL. 8. ISSUE 4. P. 451 -458 | 17 | 71% | 17 |
9 | PRENDERGAST, A , LINBO, TH , SWARTS, T , UNGOS, JM , MCGRAW, HF , KRISPIN, S , WEINSTEIN, BM , RAIBLE, DW , (2012) THE METALLOPROTEINASE INHIBITOR RECK IS ESSENTIAL FOR ZEBRAFISH DRG DEVELOPMENT.DEVELOPMENT. VOL. 139. ISSUE 6. P. 1141 -1152 | 28 | 43% | 14 |
10 | GUTIERREZ, J , DROPPELMANN, CA , SALSOSO, R , WESTERMEIER, F , TOLEDO, F , SALOMON, C , SANHUEZA, C , PARDO, F , LEIVA, A , SOBREVIA, L , (2016) A HYPOTHESIS FOR THE ROLE OF RECK IN ANGIOGENESIS.CURRENT VASCULAR PHARMACOLOGY. VOL. 14. ISSUE 1. P. 106 -115 | 36 | 27% | 1 |
Classes with closest relation at Level 1 |